Bando Chemical Industries, Ltd.
Fiscal Year Ending March 2027 Q2 Financial Summary
Announced the Q2 financial summary for the fiscal year ending March 2027. Revenue increased by +5.6% year-over-year, core operating income rose by +33.0%, and operating income increased excluding the impact of the prior year's one-off items. Full-year forecasts were revised reflecting currency effects. The year-end dividend was upwardly revised to 52 yen per share, with an expected annual dividend of 102 yen. Disclosed progress on the medium- to long-term plan and capital policy.
Key Figures
- Revenue: 64,757 million yen (YoY +5,663 million yen)
- Core Operating Income: 5,938 million yen (YoY +768 million yen / approximately +13% YoY)
- Operating Income: 6,774 million yen (YoY +204 million yen)
AI要約
Summary of Results
For Q2 of the fiscal year ending March 2027, consolidated results showed revenue growth driven by steady domestic and overseas sales and the impact of a weaker yen. Core operating income increased due to improvements in product mix and other factors. Although there was a reduction from the prior year's insurance proceeds, overall performance remained solid.
Outlook and Capital Policy
Based on a review of currency assumptions, full-year earnings forecasts have been revised. The dividend has been adjusted to a regular year-end dividend of 52 yen per share, with an expected annual dividend of 102 yen. Under the medium- to long-term management plan (CV-1), the company aims to achieve ROE of 12% and improve capital efficiency. Progress on share buybacks and shareholder returns will continue.
Bando Chemical Industries, Ltd.
Company overview · Stock price · Financial data · All IR
